Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H16O5 |
| Molecular Weight | 336.338 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)=CCC1=C(O)C=C2OC(=O)C3=C(OC4=CC(O)=CC=C34)C2=C1
InChI
InChIKey=YABIJLLNNFURIJ-UHFFFAOYSA-N
InChI=1S/C20H16O5/c1-10(2)3-4-11-7-14-17(9-15(11)22)25-20(23)18-13-6-5-12(21)8-16(13)24-19(14)18/h3,5-9,21-22H,4H2,1-2H3
| Molecular Formula | C20H16O5 |
| Molecular Weight | 336.338 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Psoralidin (1) was first isolated from seeds of Psoralea corylifolia Linn. It was found to be an active ingredient of many Indian and Chinese traditional herbal medicines. Psoralidin exhibits a variety of biological activities like antineoplastic, antioxidant, antibacterial, antidepressant activities. Psoralidin inhibits protein tyrosine phosphatase 1B activity. Psoralidin may act as a estrogen receptor agonist. In addition psoralidin showed potent and noncompetitive inhibition against UDP- glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25719303 | https://www.ncbi.nlm.nih.gov/pubmed/18006202
Curator's Comment: Psoralidin is CNS active in animals. No human data available.
Originator
Sources: Chakravarti KK, Bose AK, Siddiqui S. J Sci Ind Res. 1948;7B:24–26.
Curator's Comment: Psoralidin was first isolated from seeds of Psoralea corylifolia Linn in 1948 by Chakravarti et al. and later its structure was corrected by Khastgir et al. in 1961. reference was retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19254011
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cytotoxic constituents of Psoralea corylifolia. | 2001 Jun |
|
| In vitro protein tyrosine phosphatase 1B inhibitory phenols from the seeds of Psoralea corylifolia. | 2005 Jan |
|
| Fingerprint analysis of Psoralea corylifolia L. by HPLC and LC-MS. | 2005 Jul 5 |
|
| [Isolation and structure identification of a new isoflavone from Psoralea corylifolias]. | 2006 Jan |
|
| Chemical fingerprint and quantitative analysis of fructus psoraleae by high-performance liquid chromatography. | 2007 Apr |
|
| Bioactive constituents from Chinese natural medicines. XX. Inhibitors of antigen-induced degranulation in RBL-2H3 cells from the seeds of Psoralea corylifolia. | 2007 Jan |
|
| Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea Corylifolia in the forced swimming test in mice. | 2008 Feb 15 |
|
| [Studies on chemical constituents from seed of Psoralea corylifolia]. | 2008 Jun |
|
| Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia. | 2008 May 23 |
|
| Total synthesis of psoralidin, an anticancer natural product. | 2009 Apr 3 |
|
| Identification of a potent herbal molecule for the treatment of breast cancer. | 2009 Jan 30 |
|
| Induction of quinone reductase activity by psoralidin isolated from Psoralea corylifolia in mouse hepa 1c1c7 cells. | 2009 Jul |
|
| Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells. | 2009 Mar |
|
| Isolation of antioxidants from Psoralea corylifolia fruits using high-speed counter-current chromatography guided by thin layer chromatography-antioxidant autographic assay. | 2010 Aug 20 |
|
| Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer. | 2010 Feb |
|
| Psoralea corylifolia Linn.-"Kushtanashini". | 2010 Jan |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: In vivo, psoralidin effectively suppressed CTPE xenografts growth, without any observable toxicity.
Unknown
Route of Administration:
Oral
A cytotoxic coumestan derivative, psoralidin was isolated from the seed of Psoralea corylifolia. The IC50 values of 1 against SNU-1 and SNU-16 carcinoma cell lines were 53 and 203 micrograms/ml, respectively, indicating cytotoxic activity against stomach carcinoma cell lines.
Psoralidin was found to be a cytotoxic with the IC50 values of 0.3 and 0.4 microg/ml against the HT-29 (colon) and MCF-7 (breast) human cancer cell lines, respectively.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:32:21 GMT 2023
by
admin
on
Sat Dec 16 09:32:21 GMT 2023
|
| Record UNII |
G16ZUQ069L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
G16ZUQ069L
Created by
admin on Sat Dec 16 09:32:21 GMT 2023 , Edited by admin on Sat Dec 16 09:32:21 GMT 2023
|
PRIMARY | |||
|
5281806
Created by
admin on Sat Dec 16 09:32:21 GMT 2023 , Edited by admin on Sat Dec 16 09:32:21 GMT 2023
|
PRIMARY | |||
|
18642-23-4
Created by
admin on Sat Dec 16 09:32:21 GMT 2023 , Edited by admin on Sat Dec 16 09:32:21 GMT 2023
|
PRIMARY | |||
|
DTXSID20171903
Created by
admin on Sat Dec 16 09:32:21 GMT 2023 , Edited by admin on Sat Dec 16 09:32:21 GMT 2023
|
PRIMARY | |||
|
m442
Created by
admin on Sat Dec 16 09:32:21 GMT 2023 , Edited by admin on Sat Dec 16 09:32:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
Psoralidin
Created by
admin on Sat Dec 16 09:32:21 GMT 2023 , Edited by admin on Sat Dec 16 09:32:21 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
